Welcome to the Stocktwits Top 25 Newsletter this week!

The Stocktwits Top 25 reports the 25 best-performing stocks in the S&P 500, Nasdaq 100, and Russell 2000 year to date and tracks their performances over time. To help you understand this data further, check out our FAQ page, and feel free to reach out if you have questions!

Here are the Stocktwits Top 25 Lists for this week:

Supercharge your productivity with HubSpot's comprehensive guide to Chat GPT. This free resource is your fast track to AI mastery:

Plus, in-depth sections on email composition, content creation, customer support, and data analysis.

Get The Free Guide

The tech selloff reshuffled the year-to-date momentum ranks, while earnings gave Moderna and Airbnb enough juice to finish the week up double digits.

$PANW ( ▼ 0.26% ) · Palo Alto Networks · Nasdaq 100 #20 → #4. The biggest rank climber fell 14% on the week. Palo Alto reports Nov. 18, with its own target of roughly $9.55B in annual recurring revenue from next-generation security. A miss would put more pressure on the growth story as it integrates CyberArk. Company guidance · Earnings date

$IBRX ( ▲ 7.8% ) · ImmunityBio · Russell 2000 #17 → #2. Shares gained 4% for the week after ImmunityBio said the first European patients received Anktiva plus BCG for bladder cancer. The bigger test comes this month, when trial results will show whether adding Anktiva helps patients who haven’t previously received BCG. European rollout · Trial update

$ERAS ( ▲ 8.59% ) · Erasca · Russell 2000 #20 → #6. A 9% Friday bounce left shares roughly flat for the week. Erasca and Tango opened enrollment for a two-drug study in pancreatic and lung cancers. Updated Phase 1 data on Erasca’s drug alone are due Nov. 18–20, with durability and tolerability still to prove. Combination study · Upcoming data

$MRNA ( ▲ 5.27% ) · Moderna · S&P 500 #1. Moderna gained 15% for the week and raised its 2026 revenue growth outlook to 15%–25%, from up to 10%. Its new flu shot was approved after the annual contracting cycle, limiting how much the U.S. launch can contribute this season. Moderna earnings filing

$ABNB ( ▲ 11.67% ) · Airbnb · Nasdaq 100 #15. Airbnb rose 16% for the week after bookings accelerated, management lifted its full-year outlook, and the board authorized another $12B in buybacks. The holiday quarter has a wrinkle: Airbnb expects its adjusted margin to slip year over year, partly because of marketing spend. Airbnb results

Next week’s swing factor. October CPI lands Tuesday at 8:30 am ET. A hot reading could push Treasury yields higher and test Friday’s rebound. BLS calendar

Want to see some change? Respond to this email and reach me, Kevin Travers, with feedback. Follow me on Stocktwits. Send me charts and ideas! Refer a friend for this quarter’s edition of The RIP Forecast 😎

Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital, and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The Content is to be used for informational and entertainment purposes only and the Service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on Content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which Content is published on the Service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍

Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋